Cover Image

Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial

Background: Patients with type 2 diabetes mellitus (T2DM) remain at increased cardiovascular residual risk and endothelial dysfunction, even after optimizing metabolic control and treatment by sodium-glucose-2 transporter inhibitors (SGLT2-is). The present study was based on the hypothesis that prop...

Full description

Saved in:
Bibliographic Details
Main Authors: Ikaro Breder (Author), Jessica Cunha Breder (Author), Isabella Bonilha (Author), Daniel B. Munhoz (Author), Sheila T. Kimura Medorima (Author), Daniela C. Oliveira (Author), Helison R. do Carmo (Author), Camila Moreira (Author), Anatol Kontush (Author), Francesca Zimetti (Author), Ilaria Zanotti (Author), Luiz Sergio F. Carvalho (Author), Wilson Nadruz (Author), Elza Muscelli (Author), Thiago Quinaglia (Author), Andrei C. Sposito (Author)
Format: Book
Published: SAGE Publishing, 2020-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items